SMS Pharma’s Vizag plant receives WHO prequalification

SMS Prescription drugs’ manufacturing (Unit VII) facility in Visakhapatnam, Andhra Pradesh, has obtained prequalification approval from the World Well being Group (WHO).

Aside from enhancing the corporate’s international regulatory standing, the pre-qualification will allow it to extend presence within the international marketplace for anti-retroviral (ARV) lively pharmaceutical elements (API), the corporate stated on Friday.

API and intermediates for international clients is the main focus of SMS Prescription drugs, which operates two manufacturing services in Hyderabad and Vizag, with capacities of 120 KL and three,000 KL respectively.